Pharmacology

25I-NBOMe has efficacy at the 5-HT2A receptor where it acts as an unusually potent and selective partial agonist. However, the role of these interactions and how they result in the psychedelic experience continues to remain elusive.

Among psychedelics, this compound is considered to be pharmacologically unique in terms of the high potency, affinity, and selectivity with which it binds to the 5-HT2a receptor. Contrary to popular belief, it is not a "full agonist", although questions have been raised about how the effects it produces differ from other 5-HT2a partial agonists, which include the range of traditional psychedelics.

The Ki values of the following targets were greater than 500 Ki: 5-HT1A, D3, H2, 5-HT1D, α1A adrenergic, δ opioid, serotonin reuptake transporter, 5-HT5A, 5-HT1B, D2, 5-HT7, D1, 5-HT3, 5-HT1E, D5, muscarinic M1-M5, H3, and the dopamine reuptake transporter.

Ki-values

Receptor Ki(nM) ±
5-HT2A 0.044  
5-HT2B 231 73
5-HT2C 2  
5-HT6 73 12
H1 189 35
κ-opioid 288 50
μ-opioid 82 14
Donations
----------------------------------------------------------------------------------------------
BTC:37BjbqkkPetMHawDExLLptjJ3c5CaVDHVM
BCH:qq7wnq53j8suz60gt4n0xhsnhug9k04ay5dqg7f325
ETH:0xba8197E679563bDbC0Cb9c606E16b0690831cfB1
ETC:0x302C9686C157a8abfeb9C0F24935d093c11FA6F1
LTC:MP8fkg9LJgWJTGf8azbYDFg3w8j6QbCpMm
ZEC:t1VRZHhjzSYAyhB1T2ChJvXWdeYDt3tnZrz
 
© 2018 25I-NBOMe. All Rights Reserved. Resigned By ITCare247